骨科器械相关感染翻修术后的围术期心肌损伤与死亡率
研究前瞻性纳入2014年7月至2016年10月间接受大型骨科手术的高心血管风险连续患者,用高敏肌钙蛋白T系列检测筛查围术期心肌损伤(PMI)。假体周围关节感染(PJI)翻修术患者PMI率43.8%(14/32)显著高于无菌翻修或初次关节置换术患者的14.5%(57/393),校正比值比为4.7;骨折相关感染(FRI)翻修术后的PMI率与一年死亡率与无菌长骨骨折手术相当。
要点
- PJI翻修术患者PMI率为43.8%(14/32),显著高于无菌关节手术的14.5%(57/393)。
- PJI翻修术PMI的多变量校正比值比为4.7(95%CI 2.1至10.7;p<0.001)。
- PJI翻修术一年死亡率18.6%(6/32)高于无菌关节手术7.4%(29/393),校正后未达统计学显著。
核心结论
- 接受PJI翻修术的患者相比无菌关节置换术患者存在PMI和死亡风险。
- 作者认为大型骨与关节感染应考虑PMI筛查并在专门的多学科单元中治疗。
研究设计与样本
- 前瞻性纳入2014年7月至2016年10月间接受脓毒性或无菌性大型骨科手术的连续高心血管风险患者,高心血管风险定义为年龄≥45岁且存在冠脉、外周或脑血管疾病,或任何年龄≥65岁者,且术后住院时间>24小时。
- 所有患者接受高敏肌钙蛋白T系列测量以系统筛查PMI,评估一年全因死亡率,采用多变量逻辑回归比较PJI或FRI脓毒性翻修术与无菌大型骨关节手术患者的PMI发生率和死亡率。
- 共纳入911例连续患者。
主要发现
- 总体PMI率为15.4%(140例)。
- PJI翻修术PMI率为43.8%(14/32),无菌翻修或初次关节置换术为14.5%(57/393),p=0.001。
- PJI翻修术一年死亡率为18.6%(6/32),无菌翻修或初次关节置换术为7.4%(29/393),p=0.038。
- 多变量分析中PJI翻修术与PMI的关联持续存在,校正比值比为4.7(95%CI 2.1至10.7;p<0.001);一年死亡率校正比值比为1.9(95%CI 0.7至5.4;p=0.240),未达统计学显著。
- FRI翻修术后PMI率为15.2%(5/33),无菌长骨骨折手术为14.1%(64/453);一年死亡率分别为15.2%(5/33)与9.1%(41/453)。
关键数值与推荐
- PMI通过高敏肌钙蛋白T系列测量筛查。
- PJI翻修术PMI率43.8%(14/32)对比无菌翻修或初次关节置换术14.5%(57/393),p=0.001。
- PJI翻修术一年死亡率18.6%(6/32)对比无菌翻修或初次关节置换术7.4%(29/393),p=0.038。
- PJI翻修术PMI的校正比值比为4.7(95%CI 2.1至10.7;p<0.001);一年死亡率校正比值比为1.9(95%CI 0.7至5.4;p=0.240)。
临床怎么用
- 作者认为大型骨与关节感染应考虑PMI筛查并在专门的多学科单元中治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Periprosthetic joint infections (PJIs) and fracture-related infections (FRIs) are associated with a significant risk of adverse events. However, there is a paucity of data on cardiac complications following revision surgery for PJI and FRI and how they impact overall mortality. Therefore, this study aimed to investigate the risk of perioperative myocardial injury (PMI) and mortality in this patient cohort. METHODS: We prospectively included consecutive patients at high cardiovascular risk (defined as age ≥ 45 years with pre-existing coronary, peripheral, or cerebrovascular artery disease, or any patient aged ≥ 65 years, plus a postoperative hospital stay of > 24 hours) undergoing septic or aseptic major orthopaedic surgery between July 2014 and October 2016. All patients received a systematic screening to reliably detect PMI, using serial measurements of high-sensitivity cardiac troponin T. All-cause mortality was assessed at one year. Multivariable logistic regression models were applied to compare incidence of PMI and mortality between patients undergoing septic revision surgery for PJI or FRI, and patients receiving aseptic major bone and joint surgery. RESULTS: In total, 911 consecutive patients were included. The overall perioperative myocardial injury (PMI) rate was 15.4% (n = 140). Septic revision surgery for PJI was associated with a significantly higher PMI rate (43.8% (14/32) vs 14.5% (57/393); p = 0.001) and one-year mortality rate (18.6% (6/32) vs 7.4% (29/393); p = 0.038) compared to aseptic revision or primary arthroplasty. The association with PMI persisted in multivariable analysis with an adjusted odds ratio (aOR) of 4.7 (95% confidence interval (CI) 2.1 to 10.7; p < 0.001), but was not statistically significant for one-year mortality (aOR 1.9 (95% CI 0.7 to 5.4; p = 0.240). PMI rate (15.2% (5/33) vs 14.1% (64/453)) and one-year mortality (15.2% (5/33) vs 9.1% (41/453)) after FRI revision surgery were comparable to aseptic long-bone fracture surgery. CONCLUSION: Patients undergoing revision surgery for PJI were at a risk of PMI and death compared to those undergoing aseptic arthroplasty surgery. Screening for PMI and treatment in specialized multidisciplinary units should be considered in major bone and joint infections. Cite this article: Bone Joint J 2022;104-B(6):696-702.
引用
- Kvarda P, Puelacher C, Clauss M, et al. Perioperative myocardial injury and mortality after revision surgery for orthopaedic device-related infection. Bone Joint J. 2022. PMID: 35638215. doi:10.1302/0301-620X.104B6.BJJ-2021-1486.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。